GLP Watchdog

HumeCare+ vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. HumeCare+ has none. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

HumeCare+ / SkinnyRx

HumeCare+ logo

HumeCare+

6.6/10

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$248/moBrand-name semaglutide pill
States
46 states and DC
47 states
Checked
Prices captured Record checked November 2026
Prices captured Record checked October 2026
Visit HumeCare+
Visit SkinnyRx

Both HumeCare+ and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (HumeCare+ 6.6, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. HumeCare+ has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral tirzepatide.

  5. 05

    SkinnyRx covers one state HumeCare+ does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

HumeCare+

SkinnyRx

Compounded semaglutide injection

$199/mo

$2,388 a year

$99/mo

first month only; not compared

Compounded tirzepatide injection

$299/mo

$3,588 a year

$99/mo

first month only; not compared

Compounded oral semaglutide

$199/mo

$2,388 a year

$149/mo

first month only; not compared

Brand-name semaglutide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
Membership fee refunded if the clinician finds you ineligible (an included device may be kept or returned at Hume's expense); otherwise non-refundable, no pro-rated refunds
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. HumeCare+: August 14, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for HumeCare+

6.6/10
  • No FDA warning letter on record
  • Names no compounding pharmacy
Visit HumeCare+

The case for SkinnyRx

6.3/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which HumeCare+ does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

HumeCare+ 6.6 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.0A
vs
B
2.0

Accessibility10%

9.4A
vs
B
9.5

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

HumeCare+ vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. HumeCare+ has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
HumeCare+ states you can cancel at any time; refunds: membership fee refunded if the clinician finds you ineligible (an included device may be kept or returned at hume's expense); otherwise non-refundable, no pro-rated refunds. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
Both HumeCare+ and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (HumeCare+ 6.6, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks